MediPharm Labs (MEDIF) Short Interest Ratio & Short Volume $0.06 +0.00 (+5.56%) As of 04/23/2025 03:59 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartHeadlinesShort InterestBuy This Stock MediPharm Labs Short Interest DataMediPharm Labs (MEDIF) has a short interest of 117,100 shares. This marks a -42.91% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 111,846 shares to cover all short positions.Current Short Interest117,100 sharesPrevious Short Interest205,100 sharesChange Vs. Previous Month-42.91%Dollar Volume Sold Short$7,869.12Short Interest Ratio0.2 Days to CoverLast Record DateMarch 31, 2025Today's Trading Volume11,462 sharesAverage Trading Volume111,846 sharesToday's Volume Vs. Average10% Short Selling MediPharm Labs? Sign up to receive the latest short interest report for MediPharm Labs and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMEDIF Short Interest Over TimeMEDIF Days to Cover Over TimeMEDIF Percentage of Float Shorted Over Time MediPharm Labs Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2025117,100 shares $7,869.12 -42.9%N/A0.2 $0.07 3/15/2025205,100 shares $11,813.76 -30.1%N/A1.2 $0.06 2/28/2025293,300 shares $14,078.40 -31.3%N/A2.1 $0.05 2/15/2025426,700 shares $21,249.66 -1.8%N/A2.3 $0.05 1/31/2025434,400 shares $19,852.08 -14.1%N/A2.6 $0.05 1/15/2025505,500 shares $25,527.75 -15.3%N/A2.8 $0.05 12/31/2024597,100 shares $24,660.23 -15.9%N/A1.4 $0.04 12/15/2024710,100 shares $31,954.50 -2.5%N/A2.6 $0.05 11/30/2024728,000 shares $34,944.00 -5.1%N/A4.5 $0.05 11/15/2024766,900 shares $39,188.59 -10.8%N/A1.9 $0.05 Get the Latest News and Ratings for MEDIF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MediPharm Labs and its competitors with MarketBeat's FREE daily newsletter. 10/31/2024860,100 shares $44,725.20 -3.4%N/A3 $0.05 10/15/2024890,300 shares $46,829.78 -6.4%N/A6.7 $0.05 9/30/2024950,700 shares $47,535.00 No ChangeN/A7.9 $0.05 9/15/2024950,700 shares $44,968.11 No ChangeN/A12.4 $0.05 8/31/2024950,700 shares $44,682.90 -0.4%N/A10.2 $0.05 8/15/2024954,800 shares $49,649.60 -1.8%N/A10.2 $0.05 7/31/2024971,800 shares $51,602.58 -5.1%N/A7.4 $0.05 7/15/20241,023,600 shares $53,124.84 -10.4%N/A9.3 $0.05 6/30/20241,142,000 shares $62,918.49 -0.5%N/A8.7 $0.06 6/15/20241,147,200 shares $61,489.92 +0.4%N/A15.8 $0.05 5/31/20241,142,200 shares $65,790.72 +1.6%N/A6.8 $0.06 5/15/20241,124,100 shares $71,043.12 -2.6%N/A4.3 $0.06 4/30/20241,153,800 shares $79,035.30 -1.5%N/A4.6 $0.07 4/15/20241,171,900 shares $67,032.68 -1.8%N/A12.6 $0.06 3/31/20241,192,800 shares $75,384.96 +2.0%N/A3.4 $0.06 3/15/20241,169,500 shares $56,486.85 -4.0%N/A6.5 $0.05 2/29/20241,218,200 shares $60,057.26 -1.8%N/A5 $0.05 2/15/20241,240,000 shares $63,984.00 -1.8%N/A7 $0.05 1/15/20241,237,300 shares $66,443.01 -0.9%N/A5.1 $0.05 12/31/20231,249,100 shares $60,706.26 +0.1%N/A5.3 $0.05 12/15/20231,248,500 shares $59,928.00 -15.4%N/A6.1 $0.05 11/30/20231,475,900 shares $70,990.79 +14.5%N/A7.3 $0.05 11/15/20231,288,700 shares $64,821.61 -3.6%N/A4.7 $0.05 10/31/20231,337,200 shares $70,203.00 -2.6%N/A7.3 $0.05 10/15/20231,373,400 shares $71,416.80 -0.3%N/A10.3 $0.05 9/30/20231,377,200 shares $73,267.04 -1.2%N/A4.8 $0.05 9/15/20231,393,800 shares $85,718.70 -6.1%N/A4 $0.06 8/31/20231,484,200 shares $94,840.38 +8.5%N/A5.6 $0.06 8/15/20231,367,500 shares $81,092.75 +3.6%N/A3.8 $0.06 7/31/20231,319,900 shares $58,207.59 -2.3%N/A8.5 $0.04Silicon Valley Gold Rush (Ad)A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.Gates and Altman are betting big—see why 7/15/20231,351,000 shares $63,497.00 +3.8%N/A8 $0.05 6/30/20231,302,000 shares $59,501.40 -1.7%N/A4.3 $0.05 6/15/20231,324,900 shares $66,245.00 -1.7%N/A4.6 $0.05 5/31/20231,348,100 shares $68,483.48 +2.0%N/A9.7 $0.05 5/15/20231,322,000 shares $75,354.00 -2.0%N/A19 $0.06 4/30/20231,349,200 shares $74,206.00 -16.8%N/A3.7 $0.06 4/15/20231,621,500 shares $113,505.00 +20.4%N/A2.5 $0.07 3/31/20231,346,600 shares $68,676.60 -4.2%N/A21.9 $0.05 3/15/20231,405,300 shares $74,480.90 +3.7%N/A5.6 $0.05 2/28/20231,355,300 shares $78,607.40 -3.2%N/A8.2 $0.06 2/15/20231,399,400 shares $87,462.50 +1.3%N/A12.9 $0.06 1/31/20231,381,700 shares $84,283.70 -2.5%N/A6.2 $0.06 1/15/20231,417,100 shares $76,523.40 +1.7%N/A13.3 $0.05 12/30/20221,393,500 shares $67,863.45 -3.1%N/A6.2 $0.05 12/15/20221,438,500 shares $77,679.00 -2.5%N/A11.3 $0.05 11/30/20221,475,000 shares $93,662.50 -14.5%N/A5.5 $0.06 11/15/20221,725,000 shares $109,020.00 -5.1%N/A3.9 $0.06 10/31/20221,816,900 shares $106,833.72 -0.1%N/A13.7 $0.06 10/15/20221,818,200 shares $97,364.61 -6.8%N/A9.5 $0.05 9/30/20221,951,600 shares $104,410.60 -9.8%N/A11 $0.05 9/15/20222,162,500 shares $122,276.40 -0.3%N/A23.8 $0.06 8/31/20222,168,700 shares $117,109.80 +7.7%N/A9.4 $0.05 8/15/20222,014,400 shares $136,576.32 -4.6%N/A9.9 $0.07 7/31/20222,111,200 shares $136,383.52 -12.3%N/A10.7 $0.06 7/15/20222,406,800 shares $126,838.36 +2.7%N/A11 $0.05 6/30/20222,344,500 shares $131,057.55 -4.1%N/A8.6 $0.06 6/15/20222,443,800 shares $131,965.20 -9.1%N/A8.9 $0.05 5/31/20222,689,500 shares $166,749.00 -10.6%N/A6.7 $0.06 5/15/20223,007,700 shares $202,117.44 +1.8%N/A6.8 $0.07 4/30/20222,953,500 shares $282,206.93 -6.3%N/A9.5 $0.10 4/15/20223,152,400 shares $337,227.99 +2.2%N/A11.3 $0.11 3/31/20223,084,500 shares $459,590.50 -10.8%N/A9 $0.15 3/15/20223,458,400 shares $390,453.36 +1.7%N/A8.3 $0.11 2/28/20223,400,000 shares $433,840.00 -5.2%N/A6.4 $0.13 2/15/20223,585,800 shares $485,158.74 -26.4%N/A9.2 $0.14 1/31/20224,871,000 shares $780,821.30 -0.4%N/A14.1 $0.16 1/15/20224,891,200 shares $842,753.76 -31.6%N/A23.3 $0.17 12/31/20217,150,600 shares $1.05 million +13.9%N/A8.5 $0.15 12/15/20216,278,900 shares $879,046.00 +20.8%N/A10.7 $0.14 11/30/20215,197,300 shares $847,159.90 +4.9%N/A9.6 $0.16 11/15/20214,955,000 shares $1.09 million -4.1%N/A17.2 $0.22 10/29/20215,164,700 shares $1.07 million +5.2%N/A21.6 $0.21 10/15/20214,911,000 shares $1.07 million -6.2%N/A15.6 $0.22 9/30/20215,234,700 shares $1.05 million -55.6%N/A13.1 $0.20 9/15/202111,776,100 shares $3.04 million -3.1%N/A41.6 $0.26 8/31/202112,146,300 shares $3.27 million -0.6%N/A32.2 $0.27 8/13/202112,225,000 shares $3.83 million -1.8%N/A48.3 $0.31 7/30/202112,444,200 shares $4.32 million -1.7%N/A52.4 $0.35 7/15/202112,652,700 shares $4.49 million -0.3%N/A50.3 $0.36 6/30/202112,690,000 shares $4.71 million +4.4%N/A38.4 $0.37Silicon Valley Gold Rush (Ad)A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.Gates and Altman are betting big—see why 6/15/202112,160,800 shares $4.80 million +11.6%N/A21.6 $0.39 5/28/202110,898,900 shares $5.01 million +19.5%N/A18.9 $0.46 5/14/20219,118,700 shares $2.96 million +8.4%N/A12 $0.32 4/30/20218,411,900 shares $3.27 million +6.2%N/A18.5 $0.39 4/15/20217,921,300 shares $2.98 million -11.6%N/A9.3 $0.38 3/31/20218,958,500 shares $3.23 million +32.7%N/A9.6 $0.36 3/15/20216,750,300 shares $2.65 million +35.4%N/A2.8 $0.39 2/26/20214,986,000 shares $2.89 million -57.7%N/A2.5 $0.58 2/12/202111,790,200 shares $8.39 million -0.5%N/A4.4 $0.71 1/29/202111,845,300 shares $5.93 million -1.8%N/A10.7 $0.50 1/15/202110,330,600 shares $6.82 million +27.0%N/A19.3 $0.66 12/31/202011,346,600 shares $4.46 million +9.8%N/A17.8 $0.39 12/15/202010,330,600 shares $4.44 million +27.0%N/A19.3 $0.43 11/30/20208,134,000 shares $3.42 million +40.1%N/A10.3 $0.42 11/15/20205,806,800 shares $3.36 million +26.3%N/A12.4 $0.58 10/30/20204,598,000 shares $2.89 million +5.7%N/A14.8 $0.63 10/15/20204,349,400 shares $3.17 million +2.6%N/A13 $0.73 9/30/20204,237,500 shares $2.78 million +19.1%N/A14.9 $0.66 9/15/20203,558,300 shares $2.60 million -9.0%N/A9.5 $0.73 8/31/20203,910,500 shares $2.82 million -30.6%N/A11 $0.72 8/14/20205,637,100 shares $4.13 million -1.9%N/A21.8 $0.73 7/31/20205,745,100 shares $4.57 million +0.9%N/A16.5 $0.80 7/15/20205,694,800 shares $4.95 million +4.4%N/A16.7 $0.87 6/30/20205,457,500 shares $4.90 million +30.6%N/A6 $0.90 6/15/20204,178,600 shares $5.56 million -2.6%N/A6.4 $1.33 5/29/20204,291,100 shares $5.99 million +11.8%N/A7.3 $1.40 5/15/20203,839,900 shares $4.80 million -0.6%N/A10.9 $1.25 4/30/20203,731,800 shares $5.26 million +8.4%N/A11.1 $1.41 MEDIF Short Interest - Frequently Asked Questions What is MediPharm Labs' current short interest? Short interest is the volume of MediPharm Labs shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 117,100 shares of MEDIF short. Learn More on MediPharm Labs' current short interest. Is MediPharm Labs' short interest increasing or decreasing? MediPharm Labs saw a decline in short interest during the month of March. As of March 31st, there was short interest totaling 117,100 shares, a decline of 42.9% from the previous total of 205,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks. What does it mean to sell short MediPharm Labs stock? Short selling MEDIF is an investing strategy that aims to generate trading profit from MediPharm Labs as its price is falling. MEDIF shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against MediPharm Labs? A short squeeze for MediPharm Labs occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MEDIF, which in turn drives the price of the stock up even further. How often is MediPharm Labs' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MEDIF, twice per month. The most recent reporting period available is March, 31 2025. More Short Interest Resources from MarketBeat Related Companies TGIFF Short Squeeze CATV Short Squeeze FFNTF Short Squeeze ABSCF Short Squeeze ACRHF Short Squeeze ACRDF Short Squeeze ALEAF Short Squeeze LBTSF Short Squeeze ALVOW Short Squeeze ERBB Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:MEDIF) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MediPharm Labs Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share MediPharm Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MEDIF Stock Free MEDIF Stock Alerts